These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9014491)

  • 41. Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.
    Cardozo MG; Hopfinger AJ
    Mol Pharmacol; 1991 Dec; 40(6):1023-8. PubMed ID: 1758437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solution NMR structure investigation for releasing mechanism of neocarzinostatin chromophore from the holoprotein.
    Takashima H; Yoshida T; Ishino T; Hasuda K; Ohkubo T; Kobayashi Y
    J Biol Chem; 2005 Mar; 280(12):11340-6. PubMed ID: 15640161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular models of neocarzinostatin damage of DNA: analysis of sequence dependence in 5'GAGCG:5'CGCTC.
    Galat A; Goldberg IH
    Nucleic Acids Res; 1990 Apr; 18(8):2093-9. PubMed ID: 2139934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitumor mechanisms of zinostatin stimalamer (YM881).
    Tanaka S; Yamamoto M; Numasaki Y
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The biological effect of a nonprotein component removed from neocarzinostatin (NCS).
    Ohtsuki K; Ishida N
    J Antibiot (Tokyo); 1980 Jul; 33(7):744-50. PubMed ID: 6447677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unstability of neocarzinostatin-chromophore.
    Edo K; Sato H; Saito K; Akiyama Y; Kato M; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1986 Apr; 39(4):535-40. PubMed ID: 2423490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mechanism of oxidative DNA strand scission].
    Sugiyama H
    Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1444-56. PubMed ID: 7568946
    [No Abstract]   [Full Text] [Related]  

  • 48. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction.
    Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Base substitution mutations induced in the cI gene of lambda phage by neocarzinostatin chromophore: correlation with depyrimidination hotspots at the sequence AGC.
    Povirk LF; Goldberg IH
    Nucleic Acids Res; 1986 Feb; 14(3):1417-26. PubMed ID: 2937016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spontaneous generation of a biradical species of neocarzinostatin chromophore: role in DNA bulge-specific cleavage.
    Hensens OD; Chin DH; Stassinopoulos A; Zink DL; Kappen LS; Goldberg IH
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4534-8. PubMed ID: 8183944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absolute configuration of the amino sugar moiety of the neocarzinostatin chromophore.
    Edo K; Akiyama Y; Saito K; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1986 Nov; 39(11):1615-9. PubMed ID: 2947887
    [No Abstract]   [Full Text] [Related]  

  • 52. Recognition of bulged DNA by a neocarzinostatin product via an induced fit mechanism.
    Yang CF; Jackson PJ; Xi Z; Goldberg IH
    Bioorg Med Chem; 2002 May; 10(5):1329-35. PubMed ID: 11886796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydrogen bromide adduct of neocarzinostatin chromophore: one of the stable derivatives of native neocarzinostatin chromophore.
    Edo K; Akiyama-Murai Y; Saito K; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1988 Sep; 41(9):1272-4. PubMed ID: 2972669
    [No Abstract]   [Full Text] [Related]  

  • 54. Neocarzinostatin chromophore: presence of a highly strained ether ring and its reaction with mercaptan and sodium borohydride.
    Hensens OD; Dewey RS; Liesch JM; Napier MA; Reamer RA; Smith JL; Albers-Schönberg G; Goldberg IH
    Biochem Biophys Res Commun; 1983 Jun; 113(2):538-47. PubMed ID: 6223633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RNA cleavage by C-1027 chromophore, an enediyne antitumor antibiotic: high selectivity to an anticodon arm.
    Totsuka R; Aizawa Y; Uesugi M; Okuno Y; Matsumoto T; Sugiura Y
    Biochem Biophys Res Commun; 1995 Mar; 208(1):168-73. PubMed ID: 7887925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neocarzinostatin (NCS).
    Ishida N; Ebina T
    Jpn J Antibiot; 1977 Dec; 30 Suppl():93-103. PubMed ID: 148519
    [No Abstract]   [Full Text] [Related]  

  • 57. Synthetic strategies to epoxydiynes and a key synthon of the neocarzinostatin chromophore.
    Thominet O; Baker JR; Britton H; Etheridge ZC; Soscia MG; Caddick S
    Org Biomol Chem; 2007 Nov; 5(22):3703-12. PubMed ID: 17972001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular dynamics simulations investigation of neocarzinostatin chromophore-releasing pathways from the holo-NCS protein.
    Zhao X; Wang S; Gao XF; Huang XR; Sun CC
    J Struct Biol; 2010 Jan; 169(1):14-24. PubMed ID: 19747549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid bilayer-assisted release of an enediyne antibiotic from neocarzinostatin chromoprotein.
    Hariharan P; Sudhahar CG; Chou SH; Chin DH
    Biochemistry; 2010 Sep; 49(35):7722-32. PubMed ID: 20712297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxidative DNA sugar damage by targeted antibiotic free radicals.
    Goldberg IH
    Free Radic Res Commun; 1989; 6(2-3):155-6. PubMed ID: 2526068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.